Device
ePID closed loop system
ePID closed loop system is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph early_phase_1
3
100%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
3(100.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 13 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedearly_phase_1
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
NCT01945099
completedearly_phase_1
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
NCT01856790
completedearly_phase_1
Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
NCT01787318
Clinical Trials (3)
Showing 3 of 3 trials
NCT01945099Early Phase 1
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
NCT01856790Early Phase 1
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
NCT01787318Early Phase 1
Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3